google-site-verification: googlec7193c3de77668c9.html

FDA approves gene therapy for severe leukocyte adhesion deficiency-I, a rare immune disorder

[
Dr. Donald Kohn has been developing gene therapies for rare pediatric immune disorders for over 30 years. This week, his role in a clinical trial has culminated in the first-ever U.S. Food and Drug Administration–approved therapy for severe leukocyte adhesion deficiency-I—a genetic condition characterized by recurrent infections and, often, early death.


Source link

Advertisements

See also  US patient dies from rare mosquito-borne disease

Check Also

Health board still paying for research with ‘unclear’ patient benefit

A health board is continuing to pay money to a university research centre several months …

Doubling stem cell chromosomes produces heart cells with stronger, faster contractions

[ Normal iPS cells are diploid, and cardiomyocytes derived from these diploid iPS cells mostly …

Wellbeing support demand for cancer patients in Jersey grows

Macmillan Cancer Support Jersey said a major development was the introduction of holistic needs assessments …

Leave a Reply

Available for Amazon Prime